Unlocking the potential of exosomes ‘extracellular vesicles’: drug delivery advancements and therapeutics in ocular diseases
Engineered exosome optimize targeted ocular drug dilivery: from biogenesis and isolation to crossing the ocular barriers, enabling advanced theraputics for inflammation, neuroprotection and anti-angiogenesis in eye diseases.
Authors
- Nagendra Verma (ORCID: https://orcid.org/0000-0002-3149-7764)
- Swati Arora (ORCID: https://orcid.org/0000-0003-2301-0239)
- Jahangir Ahmed (ORCID: https://orcid.org/0000-0002-1380-939X)
- Anurag Kumar Singh (ORCID: https://orcid.org/0000-0002-8859-6392)
Institutions
- University of Pittsburgh (US)
- St. Cloud State University (US)
- Thermo Fisher Scientific (United States) (US)
- Thermo Fisher Scientific (Israel) (IL)
- Banaras Hindu University (IN)
- B.S. Abdur Rahman Crescent Institute of Science & Technology (IN)
Publication Details
- Journal
- RSC Pharmaceutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5pm00097a
- Citations
- 14
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 11.28